Immunology
-
Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses
This article has 28 authors:Reviewed by ScreenIT
-
Array-based analysis of SARS-CoV-2, other coronaviruses, and influenza antibodies in convalescent COVID-19 patients
This article has 11 authors:Reviewed by ScreenIT
-
Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution
This article has 4 authors:Reviewed by ScreenIT
-
A novel biparatopic antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
This article has 26 authors:Reviewed by ScreenIT
-
Novel ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV2
This article has 8 authors:Reviewed by ScreenIT
-
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
This article has 14 authors:Reviewed by ScreenIT
-
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19
This article has 15 authors:Reviewed by ScreenIT
-
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
This article has 28 authors:Reviewed by ScreenIT
-
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
This article has 10 authors:Reviewed by ScreenIT
-
Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens
This article has 20 authors:Reviewed by ScreenIT